Alnylam Pharmaceuticals
ALNY
#612
Rank
S$44.45 B
Marketcap
$343.36
Share price
-3.19%
Change (1 day)
73.09%
Change (1 year)
Alnylam Pharmaceuticals Inc. is a biopharmaceutical company focused on the R&D and commercialization of RNA interference (RNAi) therapeutics for genetically defined diseases.

We have found no dividend yield history for this company